The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.
The FDA wrapped up 2024 with 50 new drug approvals, clearing a wave of long-awaited treatments. Meanwhile, Transcarent will ...
The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...
The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).
The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...
The FDA has granted approval for its first medication for certain patients with sleep apnea—the weight-loss drug Zepbound.
Tryngolza (olezarsen) has been approved by the U.S. Food and Drug Administration as an adjunct to diet to reduce ...
The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end ...
The federal agency advises that the drug is used in combination with a reduced-calorie diet and increased ... and Critical ...
The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections ... 2 diabetes," Cody Stanford said. The list price for Ozempic and Mounjaro each run ...
For people with obstructive sleep apnea, Zepbound should be used with a reduced-calorie diet and increased ... Although the ...